In patients with early inflammatory polyarthritis, ACPA positivity, younger age and inefficacy of the first non-biological DMARD are predictors for receiving biological therapy: Results from the Norfolk Arthritis Register

Diane Bunn, Suzanne M M Verstappen, Mark Lunt, Diane K. Bunn, David G I Scott, Deborah P M Symmons

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'In patients with early inflammatory polyarthritis, ACPA positivity, younger age and inefficacy of the first non-biological DMARD are predictors for receiving biological therapy: Results from the Norfolk Arthritis Register'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Immunology and Microbiology